Back
22nd Century Group, Inc. Vs. Zenas BioPharma, Inc. Industry Stock Comparison
Sell
24
XXII
22nd Century Group, Inc.
Last Price:
$0.76
Seasonality Move:
1310.65%
Sell
39
ZBIO
Zenas BioPharma, Inc.
Last Price:
$36.25
Seasonality Move:
-0.81%
Sell
24
22nd Century Group, Inc. (XXII)
is a Sell
Is 22nd Century Group, Inc. a Buy, Sell or Hold?
-
The current 22nd Century Group, Inc. [XXII] share price is $0.77. The Score for XXII is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
XXII is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Zenas BioPharma, Inc. (ZBIO)
is a Sell
Is Zenas BioPharma, Inc. a Buy, Sell or Hold?
-
The current Zenas BioPharma, Inc. [ZBIO] share price is $36.31. The Score for ZBIO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
ZBIO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
XXII Stock Price Chart
What is 22nd Century Group, Inc.'s stock price today?
-
The 22nd Century Group, Inc. share price today is $0.77Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XXII is experiencing buying pressure, which is a positive indicator for future bullish movement.
ZBIO Stock Price Chart
What is Zenas BioPharma, Inc.'s stock price today?
-
The Zenas BioPharma, Inc. share price today is $36.31The current trend is moderately bullish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.
XXII Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.09 | Sell |
| Relative Strength Index (14 RSI): | 32.39 | Sell |
| Chaikin Money Flow: | 147876 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.87 - 1.09) | Sell |
| Bollinger Bands (100): | (1.03 - 1.91) | Sell |
ZBIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 10.68 | Buy |
| Relative Strength Index (14 RSI): | 47.21 | Sell |
| Chaikin Money Flow: | 289999 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.8 - 41.14) | Sell |
| Bollinger Bands (100): | (19.01 - 36.29) | Buy |
XXII Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.86 | Sell |
| 20-day SMA: | 0.98 | Sell |
| 50-day SMA: | 1.12 | Sell |
| 200-day SMA: | 9.48 | Sell |
| 8-day EMA: | 0.86 | Sell |
| 20-day EMA: | 0.94 | Sell |
| 50-day EMA: | 1.26 | Sell |
| 200-day EMA: | 1713.26 | Sell |
ZBIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.86 | Sell |
| 20-day SMA: | 38.54 | Sell |
| 50-day SMA: | 35.24 | Buy |
| 200-day SMA: | 19.17 | Buy |
| 8-day EMA: | 35.64 | Buy |
| 20-day EMA: | 24.68 | Buy |
| 50-day EMA: | 12.87 | Buy |
| 200-day EMA: | 3.71 | Buy |
22nd Century Group, Inc. Earnings Growth & XXII Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Zenas BioPharma, Inc. Earnings Growth & ZBIO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.15 per share.
22nd Century Group, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Zenas BioPharma, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||